Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 12/11/2019
SIETES contiene 92833 citas

 
 
<< anterior 21 a 40 de 49 siguiente >>
Presentar resultados
Seleccionar todas
21. Cita con resumen
Roehr B. Half a million Americans use methamphetamine every week. BMJ 2005;331:476. [Ref.ID 74726]
22. Cita con resumen
Boddiger D. Metamphetamine use linked to rising HIV transmission. Lancet 2005;365:1217-8. [Ref.ID 73303]
23.Tiene citas relacionadas Cita con resumen
Markowitz M, Mohri H, Mehandru S, Shet A, Berry L, Kalyanaraman R, Kim A, Chung C, Jean-Pierre P, Horowitz A, La Mar M, Wrin T, Parkin N, Poles M, Petropoulos C, Mullen M, Boden D, Ho DD. Infection with multidrug resistant, dual-tropic HIV-1 and rapid progression to AIDS: a case report. Lancet 2005;365:1031-8. [Ref.ID 73163]
24. Cita con resumen
Maldonado R. "Éxtasis": inocuo o no. Med Clin (Barc) 2004;123:303-4. [Ref.ID 71404]
25.
Kuniyoshi SM, Jankovic J. MDMA and parkinsonism. N Engl J Med 2003;349:96-7. [Ref.ID 66759]
26.
Carrión JA, Escorsell A, Nogué S, Mas A. Insuficiencia hepática aguda grave por "éxtasis" y trasplante hepático urgente. Med Clin (Barc) 2003;121:117-9. [Ref.ID 66596]
27. Cita con resumen
Ahmad K. Asia grapples with spreading amphetamine abuse. Lancet 2003;361:1878-9. [Ref.ID 66143]
28. Cita con resumen
Runo J R, Loyd JE. Primary pulmonary hypertension. Lancet 2003;361:1533-44. [Ref.ID 65992]
29.
Schneider RK, Levenson J L, Schnoll SH. Update in addiction medicine. Ann Intern Med 2001;134:387-90. [Ref.ID 55575]
30.
Lester SJ, Baggott M, Welm S, Schiller NB, Jones RT, Foster E, Mendelson J. Cardiovascular effects of 3,4-methylenedioxymethamphetamine. A double-blind, placebo-controlled trial. Ann Intern Med 2000;133:969-73. [Ref.ID 54502]
31. Cita con resumen
Bosch X. Survey shows cocaine use by Spanish adolescents on the rise. Lancet 2000;355:2230. [Ref.ID 52345]
32. Cita con resumen
Pritchard J. Drug-induced stroke. Adv Drug React Bull 2000;202:771-4. [Ref.ID 51339]
33.
Boot BP, McGregor IS, Hall W. MDMA (Ecstasy) neurotoxicity: assessing and communicating the risks. Lancet 2000;355:1818-21. [Ref.ID 51016]
34.
Marwick C. NIDA seeking data on effect of fetal exposure to methamphetamine. JAMA 2000;283:2225-6. [Ref.ID 50786]
35.
Larkin M. Methamphetamine use could lead to long-term brain damage. Lancet 2000;355:1162. [Ref.ID 50186]
36. Cita con resumen
Palmeri A, Pichini S, Pacifici R, Zuccaro P, Lopez A. Drugs in nails: physiology, pharmacokinetics and forensic toxicology. Clin Pharmacokinet 2000;38:95-110. [Ref.ID 49420]
37.
Musto DF. The mystery of addiction. Lancet 1999;354:1. [Ref.ID 48588]
38. Cita con resumen
Breggin PR. Psychostimulants in the treatment of children diagnosed with ADHD: risks and mechanism of action. Int J Risk & Saf Med 1999;12:3-35. [Ref.ID 47537]
39. Cita con resumen
Collinson HL, Wheeler DC. Drug-induced rhabdomyolysis. Adv Drug React Bull 1999;196:747-50. [Ref.ID 44864]
40.
Anónimo. Anoretic agents - restricted use. France. WHO Pharmaceuticals Newsletter 1996;10:1. [Ref.ID 32830]
Seleccionar todas
 
<< anterior 21 a 40 de 49 siguiente >>